uniQure
QURE
$4.66
Share price
-1.17%
Change (1 day)
-75.89%
Change (1 year)
P/S ratio for uniQure (QURE)
P/S ratio as of April 2024 (TTM): 14.2
According to uniQure's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 14.222. At the end of 2023 the company had a P/S ratio of 20.4.
P/S ratio history for uniQure from 2014 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 20.4 | 104.99% |
| 2022 | 9.97 | 444.89% |
| 2021 | 1.83 | -95.73% |
| 2020 | 42.9 | -90.04% |
| 2019 | 430 | 350.97% |
| 2018 | 95.4 | 107.23% |
| 2017 | 46.0 | 717.97% |
| 2016 | 5.63 | -85.66% |
| 2015 | 39.3 | -13.23% |
| 2014 | 45.2 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | 5.00 | -64.88% | 🇺🇸 USA |
 Sanofi SNY | 2.25 | -84.18% | 🇫🇷 France |
 Sangamo Therapeutics
SGMO | 0.5606 | -96.06% | 🇺🇸 USA |
 bluebird bio
BLUE | 8.45 | -40.55% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 7.07 | -50.32% | 🇺🇸 USA |
 Avidity Biosciences RNA | 192 | 1,250.91% | 🇺🇸 USA |